47
IRUS TotalDownloads
Altmetric
Geographic variation and risk factors for systemic and limb ischemic events in patients with symptomatic peripheral artery disease: Insights from the REACH Registry.
File | Description | Size | Format | |
---|---|---|---|---|
![]() | Published version | 878.27 kB | Adobe PDF | View/Open |
Title: | Geographic variation and risk factors for systemic and limb ischemic events in patients with symptomatic peripheral artery disease: Insights from the REACH Registry. |
Authors: | Abtan, J Bhatt, DL Elbez, Y Sorbets, E Eagle, K Reid, CM Baumgartner, I Wu, D Hanson, ME Hannachi, H Singhal, PK Steg, PG Ducrocq, G REACH Registry Investigators |
Item Type: | Journal Article |
Abstract: | BACKGROUND: Patients with symptomatic peripheral artery disease (PAD) are at high risk of ischemic events. However, data about predictors of this risk are limited. HYPOTHESIS: We analyzed baseline characteristics and 4-year follow-up of patients enrolled in the international REduction of Atherothrombosis for Continued Health (REACH) Registry with symptomatic PAD and no history of stroke/transient ischemic attack to describe annual rates of recurrent ischemic events globally and geographically. METHODS: The primary outcome was systemic ischemic events (composite of cardiovascular death, myocardial infarction, or stroke) at 4 years. The secondary outcome was limb ischemic events (composite of lower limb amputation, peripheral bypass graft, and percutaneous intervention for PAD) at 2 years. Multivariate analysis identified risk factors associated with recurrent ischemic events. RESULTS: The primary endpoint rate reached 4.7% during the first year and increased continuously (by 4%-5% each year) to 17.6% by year 4, driven mainly by cardiovascular mortality (11.1% at year 4). Japan experienced lower adjusted ischemic rates (P < 0.01) vs North America. Renal impairment (P < 0.01), congestive heart failure (P < 0.01), history of diabetes (P < 0.01), history of myocardial infarction (P = 0.01), vascular disease (single or poly, P < 0.01), and older age (P < 0.01) were associated with increased risk of systemic ischemic events, whereas statin use was associated with lower risk (P = 0.03). The limb ischemic event rate was 5.7% at 2 years. CONCLUSIONS: Four-year systemic ischemic risk in patients with PAD and no history of stroke or transient ischemic attack remains high, and was mainly driven by cardiovascular mortality. |
Issue Date: | 22-Sep-2017 |
Date of Acceptance: | 30-Mar-2017 |
URI: | http://hdl.handle.net/10044/1/51648 |
DOI: | https://dx.doi.org/10.1002/clc.22721 |
ISSN: | 0160-9289 |
Publisher: | Wiley |
Start Page: | 710 |
End Page: | 718 |
Journal / Book Title: | Clinical Cardiology |
Volume: | 40 |
Issue: | 9 |
Copyright Statement: | This is an open access article freely available at https://dx.doi.org/10.1002/clc.22721 |
Keywords: | Ischemic Risk Peripheral Artery Disease Vorapaxar REACH Registry Investigators 1102 Cardiovascular Medicine And Haematology Cardiovascular System & Hematology |
Publication Status: | Published |
Open Access location: | http://onlinelibrary.wiley.com/doi/10.1002/clc.22721/epdf |
Appears in Collections: | National Heart and Lung Institute |